A detailed history of Edmp, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Edmp, Inc. holds 20,139 shares of AZN stock, worth $1.35 Million. This represents 1.3% of its overall portfolio holdings.

Number of Shares
20,139
Previous 20,140 0.0%
Holding current value
$1.35 Million
Previous $1.57 Million 0.06%
% of portfolio
1.3%
Previous 1.44%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$76.67 - $87.62 $76 - $87
-1 Reduced -0.0%
20,139 $1.57 Million
Q1 2024

Apr 24, 2024

SELL
$61.03 - $69.57 $37,899 - $43,202
-621 Reduced 2.99%
20,140 $1.36 Million
Q4 2023

Jan 25, 2024

SELL
$61.89 - $69.28 $26,488 - $29,651
-428 Reduced 2.02%
20,761 $1.4 Million
Q3 2023

Oct 23, 2023

SELL
$64.85 - $71.7 $88,649 - $98,013
-1,367 Reduced 6.06%
21,189 $1.43 Million
Q2 2023

Jul 24, 2023

SELL
$69.91 - $75.81 $3,984 - $4,321
-57 Reduced 0.25%
22,556 $1.61 Million
Q1 2023

Apr 20, 2023

SELL
$63.15 - $71.6 $72,811 - $82,554
-1,153 Reduced 4.85%
22,613 $1.57 Million
Q4 2022

Feb 06, 2023

SELL
$54.21 - $70.44 $86.1 Million - $112 Million
-1,588,052 Reduced 98.53%
23,766 $1.61 Million
Q4 2022

Feb 01, 2023

BUY
$54.21 - $70.44 $86 Million - $112 Million
1,587,325 Added 6480.73%
1,611,818 $109 Million
Q3 2022

Oct 20, 2022

SELL
$53.02 - $135.75 $29,107 - $74,526
-549 Reduced 2.19%
24,493 $1.34 Million
Q2 2022

Jul 28, 2022

SELL
$59.26 - $71.14 $9,126 - $10,955
-154 Reduced 0.61%
25,042 $1.66 Million
Q1 2022

Apr 28, 2022

SELL
$55.72 - $67.12 $15,935 - $19,196
-286 Reduced 1.12%
25,196 $1.67 Million
Q4 2021

Jan 19, 2022

SELL
$54.02 - $63.83 $111,119 - $131,298
-2,057 Reduced 7.47%
25,482 $1.48 Million
Q3 2021

Oct 20, 2021

BUY
$55.56 - $60.79 $1.53 Million - $1.67 Million
27,539 New
27,539 $1.65 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $208B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Edmp, Inc. Portfolio

Follow Edmp, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edmp, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Edmp, Inc. with notifications on news.